Movatterモバイル変換
[0]
ホーム
URL:
画像なし
夜間モード
Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Community portal
Project chat
Create a new Item
Recent changes
Random Item
Query Service
Nearby
Help
Special pages
Lexicographical data
Create a new Lexeme
Recent changes
Random Lexeme
Search
Search
English
Appearance
Donate
Create account
Log in
Personal tools
Donate
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
bevacizumab
(Q413299)
Item
Discussion
English
Read
View history
Tools
Tools
move to sidebar
hide
Actions
Read
View history
General
What links here
Related changes
Permanent link
Page information
Concept URI
Cite this page
Get shortened URL
Download QR code
Print/export
Create a book
Download as PDF
Printable version
In other projects
Appearance
move to sidebar
hide
From Wikidata
pharmaceutical drug
12-IGG1
RG-435
antiVEGF
R-435
Rhumab-VEGF
Avastin
edit
Language
Label
Description
Also known as
default for all languages
No label defined
–
English
bevacizumab
pharmaceutical drug
12-IGG1
RG-435
antiVEGF
R-435
Rhumab-VEGF
Avastin
Statements
instance of
type of chemical entity
0 references
subclass of
chemical compound
0 references
has use
medication
1 reference
stated in
DrugBank
DrugBank ID
DB00112
language of work or name
English
title
Bevacizumab
(English)
publication date
17 November 2015
biopharmaceutical
1 reference
stated in
DrugBank
DrugBank ID
DB00112
language of work or name
English
title
Bevacizumab
(English)
publication date
17 November 2015
mass
149,000
dalton
1 reference
stated in
DrugBank
DrugBank ID
DB00112
chemical formula
C₆₆₃₈H₁₀₁₆₀N₁₇₂₀O₂₁₀₈S₄₄
0 references
active ingredient in
Avastin
1 reference
European Medicines Agency product number
EMEA/H/C/000582
reference URL
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000582/human_med_000663.jsp
retrieved
22 March 2017
World Health Organisation international non-proprietary name
bevacizumab
(English)
1 reference
stated in
ChEMBL
ChEMBL ID
CHEMBL1201583
language of work or name
English
title
Bevacizumab
(English)
retrieved
19 January 2016
medical condition treated
rare urinary tract tumor
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
retinal vein occlusion
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
islet cell carcinoma
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
non-small-cell lung carcinoma
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
eye disease
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
metastatic melanoma
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
neuroendocrine carcinoma
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
colon adenocarcinoma
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
secondary neoplasm
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
peritoneum cancer
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
brain cancer
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
colon cancer
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
diabetic retinopathy
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
bladder cancer
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
bronchus carcinoma
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
Kuhnt-Junius degeneration
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
renal cell carcinoma
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
carcinoid tumor
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
rectum adenocarcinoma
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
exudative vitreoretinopathy 1
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
rectosigmoid cancer
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
macular retinal edema
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
fallopian tube carcinoma
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
anaplastic astrocytoma
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
kidney cancer
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
melanoma
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
cystoid macular edema
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
gastrointestinal carcinoma
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
rectum cancer
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
small intestine carcinoma
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
low-grade serous carcinoma
1 reference
reference URL
https://cureourovariancancer.org/wp-content/uploads/2019/08/NCCN-ovarian.pdf
pregnancy category
US pregnancy category C
1 reference
imported from Wikimedia project
English Wikipedia
subject has role
angiogenesis inhibitor
1 reference
stated in
Medical Subject Headings
MeSH descriptor ID
D000068258
retrieved
15 March 2018
immunological antineoplastic agent
1 reference
stated in
Medical Subject Headings
MeSH descriptor ID
D000068258
retrieved
15 March 2018
monoclonal antibody
1 reference
stated in
DrugBank
DrugBank ID
DB00112
language of work or name
English
title
Bevacizumab
(English)
publication date
17 November 2015
female reproductive toxicant
1 reference
stated in
California Proposition 65 list of chemicals
retrieved
19 February 2020
reference URL
https://oehha.ca.gov/chemicals/bevacizumab
developmental toxicant
reason for deprecated rank
rectification
1 reference
stated in
California Proposition 65 list of chemicals
retrieved
25 February 2020
reference URL
https://oehha.ca.gov/chemicals/bevacizumab
essential medicine
0 references
Commons category
Bevacizumab
0 references
Identifiers
CAS Registry Number
216974-75-3
1 reference
stated in
DrugBank
DrugBank ID
DB00112
language of work or name
English
title
Bevacizumab
(English)
publication date
17 November 2015
ChEMBL ID
CHEMBL1201583
1 reference
stated in
ChEMBL
ChEMBL ID
CHEMBL1201583
language of work or name
English
title
Bevacizumab
(English)
retrieved
19 January 2016
HSDB ID
8080
1 reference
stated in
Hazardous Substances Data Bank
HSDB ID
8080
publication date
28 October 2019
title
Bevacizumab
(English)
retrieved
10 May 2021
ATC code
L01XC07
1 reference
stated in
DrugBank
DrugBank ID
DB00112
language of work or name
English
title
Bevacizumab
(English)
publication date
17 November 2015
Guide to Pharmacology Ligand ID
6771
1 reference
retrieved
22 April 2020
reference URL
https://www.guidetopharmacology.org/coronavirus.jsp
MeSH descriptor ID
D000068258
subject named as
Bevacizumab
1 reference
stated in
Medical Subject Headings
MeSH descriptor ID
D000068258
retrieved
14 March 2018
MeSH tree code
D12.776.124.486.485.114.224.060.375
0 references
D12.776.124.790.651.114.224.060.438
0 references
D12.776.377.715.548.114.224.200.438
0 references
RxNorm ID
253337
1 reference
stated in
NDF-RT
NDF-RT ID
N0000148845
retrieved
26 February 2018
DrugBank ID
DB00112
0 references
UNII
2S9ZZM9Q9V
1 reference
stated in
NDF-RT
NDF-RT ID
N0000148845
language of work or name
English
title
BEVACIZUMAB
(English)
retrieved
19 January 2016
MedlinePlus drug identifier
a607001
0 references
PatientsLikeMe treatment ID
bevacizumab
0 references
NDF-RT ID
N0000148845
1 reference
stated in
NDF-RT
NDF-RT ID
N0000148845
language of work or name
English
title
BEVACIZUMAB
(English)
retrieved
19 January 2016
KEGG ID
D06409
1 reference
imported from Wikimedia project
English Wikipedia
CA PROP 65 ID
bevacizumab
0 references
DeCS ID
55974
0 references
electronic Essential Medicines List medicine ID
238
1 reference
reference URL
https://list.essentialmeds.org/medicines/238
title
eEML - Electronic Essential Medicines List
(English)
retrieved
23 October 2021
Encyclopædia Britannica Online ID
topic/bevacizumab
subject named as
bevacizumab
0 references
Freebase ID
/m/0584_3
1 reference
stated in
Freebase Data Dumps
publication date
28 October 2013
Microsoft Academic ID
2777802072
0 references
2910640057
0 references
New York Times topic ID
subject/avastin-drug
0 references
OpenAlex ID
C2777802072
1 reference
stated in
OpenAlex
retrieved
26 January 2022
reference URL
https://docs.openalex.org/download-snapshot/snapshot-data-format
Quora topic ID
Bevacizumab
0 references
ScienceDirect topic ID
agricultural-and-biological-sciences/bevacizumab
0 references
biochemistry-genetics-and-molecular-biology/bevacizumab
0 references
immunology-and-microbiology/bevacizumab
0 references
medicine-and-dentistry/bevacizumab
0 references
nursing-and-health-professions/bevacizumab
0 references
pharmacology-toxicology-and-pharmaceutical-science/bevacizumab
0 references
UK Parliament thesaurus ID
433902
subject named as
Bevacizumab
0 references
UMLS CUI
C0796392
1 reference
stated in
WikiUMLS: Aligning UMLS to Wikipedia via Cross-lingual Neural Ranking
WikiProjectMed ID
Bevacizumab
0 references
YSO ID
39032
subject named as
bevasitsumabi
bevacizumab
1 reference
stated in
YSO-Wikidata mapping project
retrieved
28 January 2022
Sitelinks
Wikipedia
(30 entries)
edit
arwiki
بيفاسيزوماب
azbwiki
بواسیزامب
cawiki
Bevacizumab
dewiki
Bevacizumab
enwiki
Bevacizumab
eswiki
Bevacizumab
etwiki
Bevatsisumaab
fawiki
بواسیزامب
fiwiki
Bevasitsumabi
frwiki
Bévacizumab
hewiki
אווסטין
hrwiki
Bevacizumab
idwiki
Bevasizumab
itwiki
Bevacizumab
jawiki
ベバシズマブ
kowiki
베바시주맙
nlwiki
Bevacizumab
orwiki
ବେଭାସିଜୁମାବ
plwiki
Bewacyzumab
ptwiki
Bevacizumab
ruwiki
Бевацизумаб
shwiki
Bevacizumab
simplewiki
Bevacizumab
slwiki
Bevacizumab
srwiki
Bevacizumab
thwiki
เบวาซิซูแมบ
trwiki
Bevasizumab
ukwiki
Бевацизумаб
viwiki
Bevacizumab
zhwiki
贝伐珠单抗
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(1 entry)
edit
commonswiki
Category:Bevacizumab
Retrieved from "
https://www.wikidata.org/w/index.php?title=Q413299&oldid=2326226922
"
Search
Search
bevacizumab
(Q413299)
Add topic
[8]
ページ先頭
©2009-2025
Movatter.jp
